Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on December 20, 2013. The filing addresses corporate governance changes, specifically the resignation of a director and the election of a new director, effective December 31, 2013, and January 1, 2014, respectively.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and compensation arrangements rather than financial performance.
Material Changes
- Director Resignation: James K. Malernee, Jr., PhD, resigned from the Board of Directors effective December 31, 2013. The resignation was voluntary to facilitate the appointment of a new director and was not due to any disagreement with the company.
- Director Election: Maria Sainz was elected to the Board effective January 1, 2014. She brings over 20 years of medical device industry experience, including roles as CEO of CardioKinetix, Inc. and Concentric Medical, Inc.
- Compensation Adjustments:
- Dr. Malernee received accelerated vesting of options for 65,000 shares and an extension of the exercise period through December 31, 2015.
- Ms. Sainz will receive a $15,000 annual retainer, meeting fees ($1,000 in-person/$500 telephone), and an initial stock option to purchase 45,000 shares vesting over three years.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk disclosed relates to the standard indemnification agreement entered into with the new director, which covers legal expenses and judgments arising from her service.
Investor Verification Checklist
- Verify the effective dates of the director transition (Dec 31, 2013, and Jan 1, 2014).
- Confirm the total number of shares subject to the new stock option grants (45,000 initial + 20,000 annual).
- Review the full text of the Indemnification Agreement (Exhibit 10.1) for specific liability limitations.
- Check subsequent filings for the appointment of Ms. Sainz to specific Board committees and associated supplemental retainers.